Identification of Mammalian Mediator Subunits with Similarities to Yeast Mediator Subunits Srb5, Srb6, Med11, and Rox3 by Sato, Shigeo et al.
Identification of Mammalian Mediator Subunits with Similarities to
Yeast Mediator Subunits Srb5, Srb6, Med11, and Rox3*□S
Received for publication, February 5, 2003
Published, JBC Papers in Press, February 12, 2003, DOI 10.1074/jbc.C300054200
Shigeo Sato‡§, Chieri Tomomori-Sato‡§, Charles A. S. Banks‡, Irina Sorokina‡, Tari J. Parmely‡,
Stephanie E. Kong‡, Jingji Jin‡, Yong Cai‡, William S. Lane¶, Christopher S. Brower,
Ronald C. Conaway‡**, and Joan Weliky Conaway‡**‡‡§§
From the ‡Stowers Institute for Medical Research, Kansas City, Missouri 64110, ¶Harvard Microchemistry and
Proteomics Analysis Facility, Harvard University, Cambridge, Massachusetts 02138, Division of Biology, California
Institute of Technology, Pasadena, California 91125, **Department of Biochemistry and Molecular Biology, Kansas
University Medical Center, Kansas City, Kansas 66160, and ‡‡Department of Biochemistry and Molecular Biology,
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190
The Mediator is a multiprotein coactivator required
for activation of RNA polymerase II transcription by
DNA binding transactivators. We recently identified a
mammalian homologue of yeast Mediator subunit Med8
and partially purified a Med8-containing Mediator com-
plex from rat liver nuclei (Brower, C. S., Sato, S., Tomo-
mori-Sato, C., Kamura, T., Pause, A., Stearman, R.,
Klausner, R. D., Malik, S., Lane, W. S., Sorokina, I., Roe-
der, R. G., Conaway, J. W., and Conaway, R. C. (2002)
Proc. Natl. Acad. Sci. U. S. A. 99, 10353–10358). Analysis
of proteins present in the most highly purified Med8-
containing fractions by tandem mass spectrometry led
to the identification of many known mammalian Media-
tor subunits, as well as four potential Mediator subunits
exhibiting sequence similarity to yeast Mediator sub-
units Srb5, Srb6, Med11, and Rox3. Here we present
direct biochemical evidence that these four proteins are
bona fide mammalian Mediator subunits. In addition,
we identify direct pairwise binding partners of these
proteins among the known mammalian Mediator sub-
units. Taken together, our findings identify a collection
of novel mammalian Mediator subunits and shed new
light on the underlying architecture of the mammalian
Mediator complex.
Transcription of eukaryotic protein-coding genes by RNA
polymerase II and the general initiation factors is controlled by
a large collection of DNA binding transcriptional activators
through the action of an intermediary multiprotein coactivator
referred to as Mediator. The Mediator complex was first iden-
tified in Saccharomyces cerevisiae and found to be composed of
more than 20 proteins (designated Srb2, Srb4, Srb5, Srb6,
Srb7, Srb8, Srb9, Srb10, Srb11, Med1, Med2, Pgd1, Med4,
Med6, Med7, Med8, Med11, Rox3, Cse2, Nut1, Nut2, Gal11,
Rgr1, and Sin4 (1)). Multiprotein mammalian Mediator com-
plexes with structural and functional properties similar to S.
cerevisiae Mediator were subsequently identified in several
laboratories and variously designated TRAP1 (thyroid hormone
receptor-associated proteins)/SMCC (SRB-MED-containing co-
factor) (2, 3), DRIP (vitamin D receptor-interacting proteins)
(4), ARC (activator-recruited cofactor) (5), CRSP (cofactor re-
quired for Sp1 activation) (6), and mouse Mediator (7). Bio-
chemical characterization of these different mammalian Medi-
ator complexes has revealed that they are composed of many of
the same proteins. Among the consensus mammalian Mediator
subunits are easily identifiable structural homologues of sev-
eral S. cerevisiae Mediator subunits, including Srb7, Med6,
Med7, Nut2, and Rgr1; in addition, recent bioinformatic evi-
dence suggests that, among the consensus mammalian Media-
tor subunits, TRFP, TRAP80, TRAP240, TRAP230, Cdk8, Cy-
clin C, TRAP220, and TRAP36 are homologous to S. cerevisiae
Mediator subunits Srb2, Srb4, Srb8, Srb9, Srb10, Srb11, Med1,
and Med4, respectively (8).
We recently identified a mammalian homologue of S. cerevi-
siae Mediator subunit Med8 and found that it is an Elongin
BC-interacting protein that can assemble with Elongins B and
C and a Cul2/Rbx1 module to reconstitute a potential E3 ubiq-
uitin ligase. As part of our effort to explore the possible rela-
tionship between Mediator and the ubiquitin pathway, we have
purified a Med8-containing Mediator complex from rat liver
nuclei. Analysis of proteins present in the most highly purified
Med8-containing fractions by ion-trap MS/MS identified many
consensus mammalian Mediator subunits, as well as additional
proteins not previously recognized as subunits of mammalian
Mediator. In this report, we identify four of these proteins as
integral subunits of the mammalian Mediator complex.
EXPERIMENTAL PROCEDURES
Materials—Anti-c-Myc (9E10) monoclonal antibody was purchased
from Roche Molecular Biochemicals. Rabbit anti-c-Myc antibody (C-
3956), anti-Flag (M2) monoclonal antibody, and anti-Flag M2 agarose
were obtained from Sigma. Anti-Med6 (E-20) antibody was from Santa
Cruz Biotechnology. Rabbit anti-Med8 antibody was raised against a
peptide corresponding to Med8 residues 247–268, and rabbit anti-p28b,
anti-Surf5, anti-HSPC296, anti-LCMR1, and anti-FLJ23445 antibodies
were raised against full-length recombinant proteins produced in either* This work was supported by National Institutes of Health Grant
R37 GM41628. The costs of publication of this article were defrayed in
part by the payment of page charges. This article must therefore be
hereby marked “advertisement” in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
□S The on-line version of this article (available at http://www.jbc.org)
includes as Supplemental Material (i) a sequence comparison of yeast
and mammalian Mediator subunits and (ii) peptide sequences obtained
from the purified rat liver Mediator complex.
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§§ To whom correspondence should be addressed. Tel.: 816-926-4091;
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1 The abbreviations used are: TRAP, thyroid hormone receptor-asso-
ciated protein; Med, Mediator; Srb, suppressor of RNA polymerase B;
SMCC, Srb-Med-containing cofactor; DRIP, vitamin D receptor-inter-
acting protein; ARC activator-recruited cofactor; CRSP, cofactor re-
quired for Sp1 activation; MS/MS, tandem mass spectrometry; GST,
glutathione S-transferase; HPLC, high pressure liquid chromatogra-
phy; PMSF, phenylmethylsulfonyl fluoride; TRFP, TATA-binding pro-
tein related factor-proximal protein.
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Escherichia coli or insect cells (Cocalico Biologicals, Inc). Rabbit anti-
TRAP80 antibody was kindly provided by Dr. R. G. Roeder.
Expression of Recombinant Proteins in Insect Cells—Sf21 cells were
cultured at 27 °C in Sf-900 II SFM (Invitrogen) with 10% fetal calf
serum, 100 units/ml penicillin, and 100 g/ml streptomycin. 1  108
Sf21 cells in suspension (for large-scale preparations used in prepara-
tive chromatography) or 1  107 Sf21 cells in monolayer cultures (for
small-scale preparations used for analytical immunoprecipitations)
were infected at a multiplicity of infection of 5–10 with the recombi-
nant baculoviruses indicated in the figures. Forty-eight hours after
infection, cells were collected and lysed in ice-cold buffer containing 50
mM Hepes-NaOH (pH 7.9), 500 mM KCl, 5 mM MgCl2, 0.2% (v/v) Triton
X-100, 20% (v/v) glycerol, 0.28 g/ml leupeptin, 1.4 g/ml pepstatin A,
0.17 mg/ml PMSF, and 0.33 mg/ml benzamidine. For large-scale prep-
arations, lysates were centrifuged at 100,000 g for 30 min at 4 °C, and
for analytical preparations, lysates were centrifuged at 10,000  g for
20 min at 4 °C. Where indicated in the figure legends, histidine-tagged
proteins were applied to a 1-ml HiTrap chelating column (Amersham
Biosciences) charged with nickel ions according to the manufacturer’s
instructions. The column was washed with buffer I (40 mM Hepes-KOH
(pH 7.6), 100 mM KCl, 20% (v/v) glycerol, 5 mM 2-mercaptoethanol, 0.28
g/ml leupeptin, 1.4 g/ml pepstatin A, 0.17 mg/ml PMSF, and 0.33
mg/ml benzamidine) containing 10 mM imidazole. The column was
eluted with a 20-column volume gradient from buffer I containing 10
mM imidazole to buffer I containing 500 mM imidazole.
RESULTS AND DISCUSSION
We previously identified in rat liver nuclear extracts a Med8-
containing Mediator complex with an apparent native molecu-
lar mass by SW4000 gel filtration of more than 1000 kDa (9).
Although the Med8 complex appeared to fractionate chromato-
graphically as a discrete species, it proved to be extremely
labile and refractory to complete purification, with estimated
yields as poor as 10% at each step of purification. As a conse-
quence, in an effort to identify proteins present in the Med8
complex, we resorted to a proteomics approach involving large
scale enrichment of the complex by multistep conventional
chromatography and HPLC followed by exhaustive sequencing
of Med8-associated proteins by HPLC/MS/MS.
Among the proteins present in the most highly enriched
Med8-containing fractions and identified by mass spectrometry
were the known mammalian Mediator subunits TRAP230,
TRAP220, TRAP80, Cdk8, Cyclin C, TRAP37, Med6, Med7,
TRFP, TRAP25, Nut2, and Soh1 (Table I in the Supplemental
Material). In addition to these known mammalian Mediator
subunits were a collection of additional proteins including the
p28b, Surf5, HSPC296, AK007855, and LCMR1 (lung cancer
metastasis-related protein 1) proteins, which were not previ-
ously recognized as consensus mammalian Mediator subunits.
The p28b protein was previously identified by protein se-
quencing as a constituent of a mammalian Mediator prepara-
tion from mouse B-cells (7), and its apparent Drosophila mela-
FIG. 1. The p28b, Surf5, HSPC296, and LCMR1 proteins are
present in the purified TRAP/SMCC mammalian mediator com-
plex. Immunoaffinity purification of the TRAP/SMCC Mediator com-
plex was carried out essentially as described (11). Six ml of undialyzed
nuclear extract (12) (30 mg protein) from either parental HeLa cells
(HeLa) or HeLa M10 cells (11) stably expressing Flag-tagged mamma-
lian Mediator subunit Nut2 (f:Nut2) were incubated with 100 l of
anti-Flag M2 agarose in buffer A (10 mM Hepes-NaOH, pH7.9, 10 mM
KCl, 1 mM MgCl2, 0.5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride,
0.1% Triton X-100) containing 0.3 M KCl for at least 4 h at 4 °C. Beads
were washed five times with 5 ml of buffer A containing 0.3 M NaCl and
once with buffer A containing 0.1 M NaCl. Bound proteins were eluted
by incubating beads twice with 100 l of buffer A containing 0.1 M NaCl
and 0.2 mg/ml Flag peptide and analyzed by Western blotting with the
antibodies indicated in the figure. Western blots were developed using
horseradish peroxidase-labeled secondary antibodies and either Super-
Signal West Dura extended duration substrate or SuperSignal West
Femto maximum sensitivity substrate (Pierce).
FIG. 2. Screening for binding partners of the p28b, Surf5,
HSPC296, and LCMR1 proteins among the known mammalian
Mediator subunits. A, reticulocyte lysates containing the indicated in
vitro translated, 35S-labeled proteins were mixed with purified, Sf21
insect cell expressed His-Flag-p28b or His-Flag-TRFP bound to anti-
Flag agarose beads or to anti-Flag agarose beads alone and incubated
for 2 h with rocking at 4 °C. The beads were washed three times in
phosphate-buffered saline. Bound proteins were eluted with SDS sam-
ple buffer, fractionated by SDS-PAGE, and visualized by PhosphorIm-
ager analysis. B, reticulocyte lysate containing the indicated 35S-labeled
proteins were incubated for 3 h at room temperature with GST or the
indicated GST fusion protein that had been expressed in and purified
from E. coli and prebound to glutathione-agarose. The beads were
washed three times with 40 mM Tris-HCl (pH 7.4), 150 mM NaCl, and
0.2% Triton X-100. Proteins were eluted with the same buffer contain-
ing 30 mM glutathione and 10% glycerol, fractionated by SDS-PAGE,
and visualized by PhosphorImager analysis. Expressed sequence tags
encoding full-length human TRAP80 (BE883062), mouse Med6
(AW990333), human Med7 (AI417176), human TRAP37 (AA447877),
human TRAP36 (BG77869), mouse TRFP (BF165981), mouse TRAP25
(BF657838), human Srb7 (AA449015), mouse Soh1 (BE626280), human
p28b (AA460637), human Surf5 (BE618264), mouse HSPC296
(BE625435), mouse LCMR1 (AW044776), mouse Gas41 (BE308730),
mouse Nut2/Med10 (BE625965), and mouse FLJ23445 (BF179247)
(GenBankTM accession numbers in parentheses) were purchased from
Invitrogen and subcloned into mammalian expression vector pcDNA3.1
with N-terminal Flag or C-Myc tags. pcDNA3.1 encoding full-length
human MED8 with an N-terminal T7 epitope tag was described previ-
ously (9). 35S-Labeled proteins used in binding studies were synthesized
using the TNT T7 quick coupled transcription/translation system (rab-
bit reticulocyte lysate from Promega) programmed with the indicated
pcDNA3.1 vectors.
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nogaster homologue was recently identified as a component of a
D. melanogaster Mediator complex (10). However, the p28b
protein had not previously been identified as a subunit of other
mammalian Mediator complexes, including the TRAP/SMCC,
DRIP, ARC, and CRSP complexes (2–6). The proteins encoded
by the Surf5, HSPC296, and AK007855 open reading frames
had not previously been identified as components of mamma-
lian Mediator complexes, but their apparent D. melanogaster
homologues were recently identified as the Med24, Med21, and
Med23 components of a D. melanogaster Mediator complex
(10). The LCMR1 protein is defined as a metastasis-related
protein (GenBankTM accession number AAN16075). however,
no information about the function of LCMR1 has been reported,
and the LCMR1 protein had not previously been identified as a
constituent of either mammalian or D. melanogaster Mediator
complexes.
On the basis of bioinformatic evidence, Bourbon and co-
workers (8) recently predicted that the p28b and Surf5 proteins
are higher eukaryotic homologues of the S. cerevisiae Mediator
subunits Srb5 and Srb6. Results of our PSI-BLAST searches
and multiple sequence alignments revealed structural similar-
ities between LCMR1 and HSPC296 and the yeast Mediator
subunits Rox3 and Med11, respectively, suggesting that
LCMR1 and HSPC296 could be mammalian homologues of
yeast Rox3 and Med11 (Fig. 1 in the Supplemental Material).
Because of their apparent structural similarities to S. cerevi-
siae Mediator subunits, we sought to determine whether the
p28b, Surf5, HSPC296, and LCMR1 proteins are bona fide
subunits of the mammalian Mediator complex. To begin to
address this possibility, we took advantage of a HeLa cell line
that stably expresses Mediator subunit Nut2 with an N-termi-
nal Flag tag (f:Nut2). This HeLa cell line has been used exten-
sively as a source for immunoaffinity purification of the tran-
scriptionally active TRAP/SMCC Mediator complex (11).
Rabbit polyclonal antibodies were raised against the p28b,
Surf5, HSPC296, and LCMR1 proteins and used in Western
blotting experiments to assay for the presence of these proteins
in immunoaffinity-purified preparations of the HeLa cell
TRAP/SMCC complex. As shown in Fig. 1, all four proteins
were readily detected by Western blotting in immunoaffinity-
purified preparations of the TRAP/SMCC complex, along with
f:Nut2 and known Mediator subunits TRAP80, Med6, and
Med8. A protein encoded by the FLJ23445 open reading frame,
which was also identified by mass spectrometry in the most
highly enriched Med8-containing fractions, was not detected by
Western blotting in purified preparations of the TRAP/SMCC
complex (Fig. 1). Thus, although the p28b, Surf5, HSPC296,
and LCMR1 proteins were not previously identified in the
TRAP/SMCC complex by protein sequencing, they were all
detected by Western blotting in purified preparations of the
complex, suggesting that they are subunits of the complex.
To obtain additional evidence supporting assignment of the
p28b, Surf5, HSPC296, and LCMR1 proteins as mammalian
Mediator subunits, we sought to identify pairwise binding part-
ners of these proteins among the known mammalian Mediator
subunits. To this end, we used a convenient and scalable screen
to assess the ability of these proteins to interact with known
mammalian Mediator subunits prepared by in vitro translation
in rabbit reticulocyte lysates. pcDNA3.1 expression vectors en-
coding the known mammalian Mediator subunits indicated in
Fig. 2 were constructed and used to program rabbit reticulocyte
lysates for translation of 35S-labeled Mediator proteins. Bind-
ing of 35S-labeled Mediator proteins to purified recombinant
Flag-p28b, Flag-TRFP, GST-Surf5, GST-TRAP25, and GST-
FIG. 3. Interaction of p28b, Surf5, HSPC296, and LCMR1 with
known Mediator subunits in transfected mammalian cells. Two
10-cm dishes of 293T cells grown to 50% confluency were cotrans-
fected with 3 g of plasmids encoding the proteins indicated in the
figure. 24–36 h after transfection, cells were lysed by incubation in 50
mM Hepes-NaOH (pH 7.9), 250 mM KCl, 0.2% (v/v) Triton X-100, and
20% (v/v) glycerol. Proteins in cell lysates or anti-Flag immunoprecipi-
tates were fractionated by SDS-polyacrylamide gel electrophoresis and
visualized by Western blotting using anti-Flag or anti-c-Myc antibodies
and horseradish peroxidase-labeled secondary antibodies. Western
blots were developed using the SuperSignal West Dura extended dura-
tion substrate (Pierce). f:TRFP, FLAG-TRFP; f:Surf5, FLAG-Surf5; f:L-
CMR1, FLAG-LCMR1; myc, c-Myc epitope; IP, immunoprecipitation.
FIG. 4. Interaction of p28b with TRFP. A, specific interaction
between bacterially expressed p28b and TRFP. 10 g of GST-p28b,
His-TRX-FLJ23445, and His-TRFP were mixed in the combinations
indicated in the figure and incubated for 3 h at room temperature in a
buffer containing 40 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 0.2% (v/v)
Triton X-100. Protein mixtures were then incubated for 1 h with 15 l
of glutathione-Sepharose 4 Fast Flow beads (Amersham Biosciences),
washed three times with 1 ml of 40 mM Tris-HCl (pH 7.4), 150 mM NaCl,
and 0.2% Triton X-100, and eluted with 25 l of 30 mM glutathione, 40
mM Tris-HCl (pH 7.5), 10% (v/v) glycerol, and 0.15 M NaCl. Eluted
proteins were fractionated by SDS-polyacrylamide electrophoresis and
visualized by staining with Coomassie Blue. B, copurification of insect
cell-expressed p28b and TRFP. His-Flag-p28b (upper panel) or His-
Flag-p28b and TRFP (lower panel), which had been expressed in insect
cells and purified by nickel chromatography as described under “Exper-
imental Procedures” were mixed and incubated at 4 °C for 60 min. The
mixture was then diluted with buffer A (40 mM Tris-HCl (pH 7.9), 10%
(v/v) glycerol, 1 mM EDTA, 1 mM dithiothreitol, 0.28 g/ml leupeptin,
1.4 g/ml pepstatin A, 0.17 mg/ml PMSF, and 0.33 mg/ml benzamidine)
to a conductivity equivalent to that of buffer A containing 100 mM KCl.
Proteins were applied to a 0.6 ml TSK DEAE-NPR HPLC column
(Tosoh-BioSep) equilibrated in buffer A containing 100 mM KCl. The
column was eluted with a 6-ml linear gradient from 100 to 500 mM KCl
in buffer A, and 200 l fractions were collected. Aliquots of the indicated
column fractions were analyzed by SDS-polyacrylamide gel electro-
phoresis, and proteins were visualized by Coomassie Blue staining. The
identities of the protein bands were confirmed by Western blotting
(data not shown).
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LCMR1 fusion proteins was assayed in pull-down experiments
using anti-Flag-agarose or glutathione-agarose beads, and
bound proteins were visualized by autoradiography. The re-
sults of these experiments revealed significant and reproduci-
ble binding (i) of p28b to Mediator subunit TRFP, (ii) of
TRAP25 to itself and to Mediator subunits TRAP36 and Surf5,
(iii) of Surf5 to both Mediator subunit TRAP25 and HSPC296,
and (iv) of LCMR1 to Mediator subunit Soh1 (Fig. 3). Addition-
ally, GST-TRAP25, GST-Surf5, and GST-LCMR1 all bound to
TRAP80 and TRAP37 in these experiments (Fig. 2).
To confirm and extend these findings, we sought to reconsti-
tute the protein-protein interactions observed in in vitro trans-
lation experiments in transfected 293T cells or with recombi-
nant proteins expressed in Sf21 insect cells or in E. coli.
Consistent with the results of our initial screening experi-
ments, p28b could be coimmunoprecipitated from 293T cell
lysates with mammalian Mediator subunit TRFP, Surf5 could
be coimmunoprecipitated with both HSPC296 and Mediator
subunit TRAP25, and LCMR1 could be coimmunoprecipitated
with Mediator subunit Soh1 (Fig. 3).
As shown in Fig. 4A, recombinant TRFP purified from E. coli,
but not bacterially expressed FLJ23445, bound specifically to
purified GST-p28b. In control experiments, TRFP did not bind
to GST-Med8. Consistent with these observations, a TRFP-
p28b heterodimer could be reconstituted with His-TRFP and
His-p28b that had been purified from baculovirus-infected in-
sect cells by nickel chromatography. TheTRFP-p28b het-
erodimer was purified to near homogeneity by TSK DEAE-NPR
HPLC. After mixing recombinant TRFP and p28b, both pro-
teins bound the TSK DEAE-NPR column and were eluted with
130 mM KCl. In control experiments p28b flowed through the
TSK DEAE-NPR column when TRFP was not present (Fig. 4B).
Similarly, an HSPC296-Surf5 heterodimer could be purified to
near homogeneity by anti-Flag immunoaffinity chromatogra-
phy of Flag-tagged HSPC296 and C-Myc-tagged Surf5 that had
been coexpressed in Sf21 cells (Fig. 5A).
To determine whether Surf5 can bind directly to TRAP25,
either GST-TRAP25 and Surf5 or GST and Surf5 were coex-
pressed in E. coli, and cell lysates were subjected to glutathi-
one-agarose chromatography. Because GST and Surf5 coelec-
trophorese on SDS-polyacrylamide gels, the presence or
absence of Surf5 in column eluates was detected by Western
blotting with anti-Surf5 antibodies. As shown in Fig. 5B, bac-
terially expressed Surf5 bound specifically to bacterially ex-
pressed GST-TRAP25 but not to GST.
FIG. 5. Interaction of HSPC296 with Surf5 and TRAP25. A,
extracts from Sf21 cells infected with baculoviruses encoding the
hSPC296 protein with an N-terminal Flag tag and the Surf5 protein
with an N-terminal Myc tag and a 16-amino acid C-terminal extension
replacing the last two Surf5 amino acids with DPLEDLVPSSNSRAAA
(input) were immunoprecipitated using anti-FLAG agarose. Bound pro-
teins were eluted from anti-FLAG beads with 150 g/ml FLAG peptide,
subjected to SDS-polyacrylamide gel electrophoresis, and detected by
Coomassie staining or by Western blotting (IP Flag). Myc:Surf5 was
detected with rabbit anti-c-Myc antibody and IR Dye™ 800-labeled goat
anti-rabbit IgG secondary antibody (green). f:hSPC296 was detected
with mouse anti-FLAG monoclonal antibody and Alexa Fluor 680-
labeled anti-mouse IgG ( light chain-specific) secondary antibody (red).
Light chain-specific anti-mouse antibody was obtained from Bethyl
Laboratories and labeled with Alexa Fluor 680 (Molecular Probes)
according to the manufacturer’s instructions. Fluorescently labeled sec-
ondary antibodies were detected using a Li-Cor Odyssey infrared im-
aging system. B, His-Surf5 and either GST or GST-TRAP25 were coex-
pressed in E. coli and purified on a glutathione-Sepharose FastFlow
column. Aliquots of the column load (input), flow-through (FT), and
fractions eluted with glutathione were subjected to SDS-polyacrylamide
gel electrophoresis, and proteins were detected by Western blotting
(WB) with anti-Surf 5 antiserum using horseradish peroxidase-labeled
secondary antibody. Bands were visualized using the SuperSignal West
Femto maximum sensitivity substrate (Pierce).
FIG. 6. Interaction of LCMR1 with Soh1. Lanes 1–4, 200 l of
lysates from Sf21 cells infected with baculoviruses expressing the indi-
cated proteins (input) were incubated for 30 min at 4 °C with 1 l of
rabbit anti-LCMR1 antiserum in 50 mM Hepes-NaOH (pH 7.9), 500 mM
KCl, 5 mM MgCl2, 0.2% (v/v) Triton X-100, 20% (v/v) glycerol, 0.28 g/ml
leupeptin, 1.4 g/ml pepstatin A, 0.17 mg/ml PMSF, and 0.33 mg/ml
benzamidine. The mixture was diluted with 0.5 ml of the same buffer
and incubated overnight at 4 °C with anti-rabbit IgG-agarose (Sigma).
Beads were washed three times with 1 ml of 40 mM Tris-HCl (pH 7.4),
137 mM NaCl, 3 mM KCl, and 0.02% (v/v) Tween 20. Bound proteins
were eluted with SDS sample buffer, analyzed by Western blotting
using rabbit anti-c-Myc primary antibody and IR Dye™ 800-labeled
goat anti-rabbit IgG secondary antibody, and visualized using a Li-Cor
Odyssey infrared imaging system. Lanes 5–6, 10 g of Trx-His-
LCMR1 (Trx-LCMR1) and 15 g of GST or 10 g of GST-Soh1 were
incubated at room temperature in 50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 10% glycerol. After 2 h, the protein mixture was added to 25 l of
glutathione agarose beads pre-equilibrated with the same buffer and
incubated an additional 1 h at room. Beads were then transferred to
Micro Bio-Spin chromatography columns (Bio-Rad) and washed with a
total of 4 ml of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% glycerol,
and 0.2% Triton X-100 and then with 1 ml of phosphate-buffered saline.
Bound proteins were eluted with 40 l of 30 mM glutathione, 40 mM
Tris-HCl (pH 7.5), 10% (v/v) glycerol, and 0.15 M NaCl.
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Finally, binding of LCMR1 to Soh1 was detected following
pairwise coexpression of these proteins in Sf21 cells. As shown
in Fig. 6, lanes 1–4, LCMR1 and Soh1 could be coimmunopre-
cipitated efficiently with anti-LCMR1 antibodies from lysates
of cells expressing both LCMR1 and Soh1, whereas only a small
amount of Soh1 was detected in immunoprecipitates from cells
expressing Soh1 alone. To determine whether LCMR1 can bind
directly to Soh1, thioredoxin-LCMR1, which had been ex-
pressed in and purified from E. coli, was mixed with either
GST-Soh1 or GST and subjected to glutathione-agarose chro-
matography. Full-length Trx-LCMR1 and GST-Soh1 coelectro-
phorese on SDS-polyacrylamide gels (data not shown). There-
fore, Trx-LCMR1 was detected by Western blotting with anti-
LCMR1 antibodies. As shown in Fig. 6, lanes 8–10, Trx-LCMR1
bound GST-Soh1 but not GST. Further supporting the speci-
ficity of this interaction, a large fraction of Trx-LCMR1 in
binding reactions had been proteolyzed during its expression
and/or purification (lanes 5–7); however, the full-length protein
bound most efficiently to GST-Soh1.
In summary, in this report we present direct biochemical
evidence that the mammalian p28b, Surf5, HSPC296, and
LCMR1 proteins are bona fide subunits of the mammalian
Mediator complex. Taken together with the bioinformatic evi-
dence of Bourbon and co-workers (8), which suggests that the
p28b and Surf5 proteins may be homologues of S. cerevisiae
Mediator subunits Srb5 and Srb6, our finding that the
HSPC296 and LCMR1 proteins share sequence similarity with
S. cerevisiae Mediator subunits Med11 and Rox3 suggests that
yeast and higher eukaryotic Mediator complexes may be more
highly conserved throughout evolution than previously
thought. Ultimately, however, experiments that directly ex-
plore the structural and functional relationships between ap-
parent homologues of yeast and higher eukaryotic Mediator
subunits will be required to determine the extent of evolution-
ary conservation between yeast and higher eukaryotic Media-
tor complexes.
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